A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome

INTRODUCTION: Both Δ(9) Tetrahydrocannabidiol (THC) and cannabidiol (CBD) components of cannabis, have been shown to have anticonvulsant effects. Cannabis oils are used to treat seizures in drug‐resistant epilepsy (DRE). Recent trials provide data on dosing, side effects, and efficacy of CBD, yet th...

Descripción completa

Detalles Bibliográficos
Autores principales: McCoy, Bláthnaid, Wang, Laura, Zak, Maria, Al‐Mehmadi, Sameer, Kabir, Nadia, Alhadid, Kenda, McDonald, Kyla, Zhang, Grace, Sharma, Rohit, Whitney, Robyn, Sinopoli, Katia, Snead, O. Carter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144444/
https://www.ncbi.nlm.nih.gov/pubmed/30250864
http://dx.doi.org/10.1002/acn3.621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144444/
https://www.ncbi.nlm.nih.gov/pubmed/30250864
http://dx.doi.org/10.1002/acn3.621

Ejemplares similares